Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-cash Items (2021 - 2022)

Cullinan Therapeutics (CGEM) has 2 years of Non-cash Items data on record, last reported at $66.0 million in Q4 2022.

  • For Q4 2022, Non-cash Items fell 12.93% year-over-year to $66.0 million; the TTM value through Dec 2022 reached $66.0 million, down 12.93%, while the annual FY2022 figure was $3.7 million, 95.11% down from the prior year.
  • Non-cash Items reached $66.0 million in Q4 2022 per CGEM's latest filing, down from $75.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $75.8 million in Q4 2021 and bottomed at $66.0 million in Q4 2022.